GenoID

GenoID is a molecular diagnostics company specializing in high-throughput genetic testing and infectious disease screening. The company gained international recognition for developing advanced real-time PCR assays for Human Papillomavirus (HPV) genotyping, which are critical for cervical cancer screening and risk assessment. In addition to its virology portfolio, GenoID offers diagnostic solutions for sexually transmitted infections, hematology, and various hereditary conditions. Following its acquisition by Synlab in 2012, GenoID's laboratory and technology were integrated into Synlab's global network, serving as a center of excellence for molecular biology in Central and Eastern Europe. The company's expertise lies in translating complex molecular research into standardized clinical diagnostic tools.